Brit. J. Cancer 28: pp. 365Powles, R. L. 1973. Immunotherapy for acute myelogen- ous leukemia. Br. J. Cancer 28(Suppl. 1):262-265.POWLES, R. L., CROWTHER, D., BATEMAN, C. J. T., BEARD, M. E. J., MCELWAIN, T. J., RussELL, J., LISTER, T. A., WHITEHOUSE, J....
Permanent human tumor cell lines are an important tool for the study of breast cancer. Two new breast cancer cell lines (BrCa-MZ-01 and BrCa-MZ-02) were is... GE Arteel,RG Thurman,JM Yates,... - 《Br J Cancer》 被引量: 477发表: 1995年 ...
Larry W Kwak, Jorge Romaguera, Michele Fanale, Luis Fayad, Robert Orlowski, Michael Wang, Francesco Turturro, Yasuhiro Oki, Linda Lacerte, Felipe Samaniego Department of Lymphoma/Myeloma MD Anderson Cancer Center, Houston, Texas Courtesy of Nathan Fowler 理论基础 新诊断的惰性NHL的最佳治疗尚未确定。
Br J Dermatol 1983;109: 165-72. 8. Green A, Bain C, McLennan R, et al. Risk factors... William,C.,Black,... - 《Cancer》 被引量: 90发表: 1988年 Pigmentary disorders in ethnic skin Pigmentary disorders are commonly seen in ethnic skin. They are psychologically problematic in ...
The impact of neoadjuvant hormone therapy on the permanent 125I-seed brachytherapy for low-or intermediate-risk prostate cancer[J]. J Clin Oncol, 2012, 30(5_suppl):201. [13] Huang ZM, Pan CC, Wu PH, et al. Efficacy of minimally invasive therapies on unresectable pancreatic cancer[J]. ...
Nagata T. The influence of iPS-inducing factors NANOG and KLF4 in the prognosis of patients with breast cancer[J]. J Clin Oncol, 2011, 29 (suppl 27): abstr 230. [6] Ohnishi S, Ohnami S, Laub F, et al. Downregulation and growth inhibitory effect of epithelial-type Krüppel-like tra...
如今,乳腺癌(BRCA)是全球癌症发病率的主要原因,也是癌症相关死亡的第二大原因(1)。三阴性乳腺癌(TNBC)的特点是人类表皮生长因子受体2(Her2)和雌激素受体/黄体酮受体(ER/PR)的表达缺失,是最具侵入性的亚型,死亡率最高,约占所有BRCA(2)的15%。首次诊断后5年内死亡率高达40%,大约46%的TNBC患者将发生远处转移...
HOCKEL,M. - 《Cancer Research》 被引量: 788发表: 1999年 Abdominal Radiation Response Modified by Hypoxia After Intra-Aortal Injection of Starch Microspheres: Experiments in the Rat 17, 353.Gray L. H., Conger A. D., Ebert M., Hornsey S., Scott O. C. A. The concentration of oxygen ...
greater immune activation and tumor controlCancer Res.78(13 Suppl.)(2018) 3.DiRenzo, D., Piovesan, D., Tan, J., et al.Abstract A162: AB928, a dual antagonist of the A2aR and A2bR adenosine receptors, relieves adenosine-mediated immune suppressionCancer Immunol. Res.7(2 Suppl.)(2019...
The role in genome stability, cancer Stemness and therapy resistance J. Cancer, 10 (2019), pp. 2109-2127, 10.7150/jca.30410 View in ScopusGoogle Scholar [8] P.A.J. Muller, K.H. Vousden p53 mutations in cancer Nat. Cell Biol., 15 (2013), pp. 2-8, 10.1038/ncb2641 View in Scop...